BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38062114)

  • 1. Tazemetostat in the therapy of pediatric INI1-negative malignant rhabdoid tumors.
    Vejmelkova K; Pokorna P; Noskova K; Faustmannova A; Drabova K; Pavelka Z; Bajciova V; Broz M; Tinka P; Jezova M; Palova H; Kren L; Valik D; Slaby O; Sterba J
    Sci Rep; 2023 Dec; 13(1):21623. PubMed ID: 38062114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C.
    Chi SN; Yi JS; Williams PM; Roy-Chowdhuri S; Patton DR; Coffey BD; Reid JM; Piao J; Saguilig L; Alonzo TA; Berg SL; Ramirez NC; Jaju A; Mhlanga JC; Fox E; Hawkins DS; Mooney MM; Takebe N; Tricoli JV; Janeway KA; Seibel NL; Parsons DW
    J Natl Cancer Inst; 2023 Nov; 115(11):1355-1363. PubMed ID: 37228094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis.
    Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J
    Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
    Bookhout C; Bouldin TW; Ellison DW
    Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
    Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical Teratoid/Rhabdoid Tumor (AT/RT) Arising From Ependymoma: A Type of AT/RT Secondarily Developing From Other Primary Central Nervous System Tumors.
    Nobusawa S; Hirato J; Sugai T; Okura N; Yamazaki T; Yamada S; Ikota H; Nakazato Y; Yokoo H
    J Neuropathol Exp Neurol; 2016 Feb; 75(2):167-74. PubMed ID: 26769252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical teratoid/rhabdoid tumor in adults: a systematic review of the literature with meta-analysis and additional reports of 4 cases.
    Broggi G; Gianno F; Shemy DT; Massimino M; Milanaccio C; Mastronuzzi A; Rossi S; Arcella A; Giangaspero F; Antonelli M
    J Neurooncol; 2022 Mar; 157(1):1-14. PubMed ID: 35217948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of BRG1 (
    Saunders J; Ingley K; Wang XQ; Harvey M; Armstrong L; Ng T; Dunham C; Bush J
    Pediatr Dev Pathol; 2020; 23(2):132-138. PubMed ID: 31403913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reclassification of rhabdoid tumor and pediatric undifferentiated/unclassified sarcoma with complete loss of SMARCB1/INI1 protein expression: three subtypes of rhabdoid tumor according to their histological features.
    Kohashi K; Tanaka Y; Kishimoto H; Yamamoto H; Yamada Y; Taguchi T; Iwamoto Y; Oda Y
    Mod Pathol; 2016 Oct; 29(10):1232-42. PubMed ID: 27338635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system.
    Bruggers CS; Bleyl SB; Pysher T; Barnette P; Afify Z; Walker M; Biegel JA
    Pediatr Blood Cancer; 2011 Jul; 56(7):1026-31. PubMed ID: 20848638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhabdoid tumor: the Irish experience 1986-2013.
    Uwineza A; Gill H; Buckley P; Owens C; Capra M; O'Sullivan C; McDermott M; Brett F; Farrell M; Pears J; O'Sullivan MJ
    Cancer Genet; 2014 Sep; 207(9):398-402. PubMed ID: 25085603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical Teratoid/Rhabdoid Tumor: Revisiting Histomorphology and Immunohistochemistry With Analysis of Cyclin D1 Overexpression and
    Sali AP; Epari S; Nagaraj TS; Sahay A; Chinnaswamy G; Shetty P; Moiyadi A; Gupta T
    Int J Surg Pathol; 2021 Apr; 29(2):155-164. PubMed ID: 32703045
    [No Abstract]   [Full Text] [Related]  

  • 15. [Central nervous system atypical teratoid/rhabdoid tumor without loss of nuclear expression of INI1].
    Ryzhova MV; Kadyrov SU; Kumirova EV; Shishkina LV; Nikitin PV; Panina TN; Shibaeva IV; Shugay SV; Starovoytov DV; Sycheva RV; Zubova IV
    Arkh Patol; 2019; 81(2):36-42. PubMed ID: 31006778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Germline INI1 mutation in a patient with a central nervous system atypical teratoid tumor and renal rhabdoid tumor.
    Biegel JA; Fogelgren B; Wainwright LM; Zhou JY; Bevan H; Rorke LB
    Genes Chromosomes Cancer; 2000 May; 28(1):31-7. PubMed ID: 10738300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical teratoid/rhabdoid tumors (ATRT): improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy.
    Tekautz TM; Fuller CE; Blaney S; Fouladi M; Broniscer A; Merchant TE; Krasin M; Dalton J; Hale G; Kun LE; Wallace D; Gilbertson RJ; Gajjar A
    J Clin Oncol; 2005 Mar; 23(7):1491-9. PubMed ID: 15735125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
    Seeringer A; Reinhard H; Hasselblatt M; Schneppenheim R; Siebert R; Bartelheim K; Leuschner I; Frühwald MC
    Cancer Genet; 2014 Sep; 207(9):429-33. PubMed ID: 25262118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atypical teratoid/rhabdoid tumors of childhood].
    Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
    Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors.
    Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB
    Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.